ArticleFrontiers in pharmacology2025

Yishenyangsui granule for degenerative cervical myelopathy: a randomized, double-blind, placebo-controlled trial with long-term follow-up.

He Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.